Back to News & Events

10th Annual Immuno-Oncology 360° Summit

Join the Center for Biotechnology at the 10th Annual Immuno-Oncology 360° Summit on February 27-29, 2024 at the New York Marriott At The Brooklyn Bridge in Brooklyn, NY!

IO360° offers an unparalleled opportunity to hear from stakeholders representing both the science and business communities who report on the latest data impacting ​​​​​​​​​​​​​​IO to fight a wider range of cancers. CFB constituents can take 15% off their registration cost with the code: CFB15 – Learn more and register here: https://io360summit.com/

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => 
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 4439
                    [post_author] => 3
                    [post_date] => 2024-07-30 15:29:07
                    [post_date_gmt] => 2024-07-30 19:29:07
                    [post_content] => 

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:38:43 [post_modified_gmt] => 2024-08-09 19:38:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 3836 [post_author] => 4 [post_date] => 2021-10-18 18:41:48 [post_date_gmt] => 2021-10-18 18:41:48 [post_content] =>

October 21, 2021
4:00pm - Online

Turning a good scientific idea into a successful biotech startup is a challenging journey.

What are the steps to building a successful biotech startup? How do startup founders find grants or investors to help them build their dreams?

This panel will highlight several successful programs that scientists can use when creating a successful biotech company. Learn what resources are available to turn your idea into a business and help you develop entrepreneurial skills.

The event will introduce funding and strategic programs available from IndieBio, the Center for Biotechnology, and SVB Startup Banking Life Sciences. Featuring Phuong Nguyen, Commercialization Fellow at the Center for Biotechnology; Stephen Chambers, Managing Director and Partner of IndieBio in New York and Anton Xavier, Director for Startup Life Science Banking in NY and the Northeast at SVB Financial Group.

https://www.eventbrite.com/e/building-funding-and-growing-successful-biotech-startups-tickets-182044860077

[post_title] => Building, Funding & Growing Successful Biotech Startups: Thursday 10/21 4:00pm [post_excerpt] => Join the Center for Biotechnology, and SVB Startup Banking Life Sciences to learn about funding and strategic programs available to help launch a successful biotech company. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => building-funding-growing-successful-biotech-startups-thursday-10-21-400pm [to_ping] => [pinged] => [post_modified] => 2021-10-28 13:15:38 [post_modified_gmt] => 2021-10-28 13:15:38 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3836 [menu_order] => 33 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 3422 [post_author] => 3 [post_date] => 2020-01-15 14:35:02 [post_date_gmt] => 2020-01-15 14:35:02 [post_content] => The IndieBio life sciences accelerator has officially launched in New York and is now accepting applications until March 1st. Each team accepted into the program will receive $250K, lab and co-working space and mentorship during the four-month program that kicks off in April 2020. IndieBio is looking for early-stage companies where biology is the underlying technology, which includes therapeutics, devices, diagnostics, computational biology as well as consumer and industrial applications, such as plant-based foods, cellular agriculture. Therapeutics companies accepted into IndieBio New York are eligible to receive up to $2 million. IndieBio, the world’s first life sciences accelerator, was created by venture fund SOSV in 2014. In the past five years, SOSV/IndieBio has backed nearly 200 life science startups with a combined valuation of over $3 billion, raising more than $700 million and employing over 2,000 people. [post_title] => Life Science Accelerator IndieBio Launches in NYC [post_excerpt] => New life science accelerator has launched in New York City, offering space, financing and more. Applications open and accepted until March 1, 2020. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => life-science-accelerator-indiebio-launches-in-nyc [to_ping] => [pinged] => [post_modified] => 2020-01-15 14:35:02 [post_modified_gmt] => 2020-01-15 14:35:02 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3422 [menu_order] => 78 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 3575 [post_author] => 3 [post_date] => 2020-07-13 11:28:25 [post_date_gmt] => 2020-07-13 11:28:25 [post_content] => BARDA and Chembio Diagnostics, Inc. are partnering to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens. This advanced lateral flow-based SARS-CoV-2 antigen detection test would run on the company’s proprietary platform. Learn more here. The Center for Biotechnology is currently a member of the BARDA DRIVe accelerator network, helping to identify promising innovation and provide wraparound technical and business development support services. [post_title] => BARDA/Chembio Diagnostics Partner on COVID-19 Detection [post_excerpt] => BARDA and Chembio Diagnostics, Inc. are partnering to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => bardachembio-diagnostics-partner-on-covid-19-detection [to_ping] => [pinged] => [post_modified] => 2021-04-07 19:12:54 [post_modified_gmt] => 2021-04-07 19:12:54 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3575 [menu_order] => 62 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4439 [post_author] => 3 [post_date] => 2024-07-30 15:29:07 [post_date_gmt] => 2024-07-30 19:29:07 [post_content] =>

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:38:43 [post_modified_gmt] => 2024-08-09 19:38:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 260 [max_num_pages] => 87 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

IAMBIC Receives $1 Million NSF SBIR Phase II Grant

More Information

Building, Funding & Growing Successful Biotech Startups: Thursday 10/21 4:00pm

More Information

Life Science Accelerator IndieBio Launches in NYC

More Information

BARDA/Chembio Diagnostics Partner on COVID-19 Detection

More Information